Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A
A 68-year-old man with hemophilia A and liver cirrhosis caused by hepatitis C virus was referred to our hospital to receive prophylactic endoscopic treatment for gastroesophageal varices (GOV). He had large, tense, and winding esophageal varices (EV) with cherry red spots extending down to lesser cu...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2010/518260 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832563786563715072 |
|---|---|
| author | Kohei Fukumoto Hideyuki Konishi Koichi Soga Ki-ichiro Miyawaki Hitoshi Okano Masahito Minami Naoki Wakabayashi Shoji Mitsufuji Norimasa Yoshida Tomohisa Takagi Nobuaki Yagi Yuji Naito Keisho Kataoka Toshikazu Yoshikawa |
| author_facet | Kohei Fukumoto Hideyuki Konishi Koichi Soga Ki-ichiro Miyawaki Hitoshi Okano Masahito Minami Naoki Wakabayashi Shoji Mitsufuji Norimasa Yoshida Tomohisa Takagi Nobuaki Yagi Yuji Naito Keisho Kataoka Toshikazu Yoshikawa |
| author_sort | Kohei Fukumoto |
| collection | DOAJ |
| description | A 68-year-old man with hemophilia A and liver cirrhosis caused by hepatitis C virus was referred to our hospital to receive prophylactic endoscopic treatment for gastroesophageal varices (GOV). He had large, tense, and winding esophageal varices (EV) with cherry red spots extending down to lesser curve, predicting the likelihood of bleeding. Esophageal endoscopic injection sclerotherapy (EIS) was performed with a total 15 mL of 5% ethanolamine oleate with iopamidol (EOI). Radiographic imaging during EIS demonstrated that 5% EOI reached the afferent vein of the varices. He was administered sufficient factor VIII concentrate before and after EIS to prevent massive bleeding from the varices. Seven days after EIS, upper gastrointestinal endoscopy (UGIE) showed that the varices were eradicated almost completely. Eighteen months after EIS, the varices continued to diminish. We report a successful case of safe and effective EIS for GOV in a high-risk cirrhotic patient with hemophilia A. |
| format | Article |
| id | doaj-art-7e412938df6c437992bd14276c6dc188 |
| institution | Kabale University |
| issn | 1687-6121 1687-630X |
| language | English |
| publishDate | 2010-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Gastroenterology Research and Practice |
| spelling | doaj-art-7e412938df6c437992bd14276c6dc1882025-02-03T01:12:33ZengWileyGastroenterology Research and Practice1687-61211687-630X2010-01-01201010.1155/2010/518260518260Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia AKohei Fukumoto0Hideyuki Konishi1Koichi Soga2Ki-ichiro Miyawaki3Hitoshi Okano4Masahito Minami5Naoki Wakabayashi6Shoji Mitsufuji7Norimasa Yoshida8Tomohisa Takagi9Nobuaki Yagi10Yuji Naito11Keisho Kataoka12Toshikazu Yoshikawa13Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanMolecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JapanA 68-year-old man with hemophilia A and liver cirrhosis caused by hepatitis C virus was referred to our hospital to receive prophylactic endoscopic treatment for gastroesophageal varices (GOV). He had large, tense, and winding esophageal varices (EV) with cherry red spots extending down to lesser curve, predicting the likelihood of bleeding. Esophageal endoscopic injection sclerotherapy (EIS) was performed with a total 15 mL of 5% ethanolamine oleate with iopamidol (EOI). Radiographic imaging during EIS demonstrated that 5% EOI reached the afferent vein of the varices. He was administered sufficient factor VIII concentrate before and after EIS to prevent massive bleeding from the varices. Seven days after EIS, upper gastrointestinal endoscopy (UGIE) showed that the varices were eradicated almost completely. Eighteen months after EIS, the varices continued to diminish. We report a successful case of safe and effective EIS for GOV in a high-risk cirrhotic patient with hemophilia A.http://dx.doi.org/10.1155/2010/518260 |
| spellingShingle | Kohei Fukumoto Hideyuki Konishi Koichi Soga Ki-ichiro Miyawaki Hitoshi Okano Masahito Minami Naoki Wakabayashi Shoji Mitsufuji Norimasa Yoshida Tomohisa Takagi Nobuaki Yagi Yuji Naito Keisho Kataoka Toshikazu Yoshikawa Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A Gastroenterology Research and Practice |
| title | Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A |
| title_full | Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A |
| title_fullStr | Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A |
| title_full_unstemmed | Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A |
| title_short | Successful Endoscopic Injection Sclerotherapy of High-Risk Gastroesophageal Varices in a Cirrhotic Patient with Hemophilia A |
| title_sort | successful endoscopic injection sclerotherapy of high risk gastroesophageal varices in a cirrhotic patient with hemophilia a |
| url | http://dx.doi.org/10.1155/2010/518260 |
| work_keys_str_mv | AT koheifukumoto successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT hideyukikonishi successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT koichisoga successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT kiichiromiyawaki successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT hitoshiokano successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT masahitominami successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT naokiwakabayashi successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT shojimitsufuji successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT norimasayoshida successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT tomohisatakagi successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT nobuakiyagi successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT yujinaito successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT keishokataoka successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa AT toshikazuyoshikawa successfulendoscopicinjectionsclerotherapyofhighriskgastroesophagealvaricesinacirrhoticpatientwithhemophiliaa |